Hybrid Closed-Loop System in Neurosurgical Perioperative Hyperglycemia: An Open RCT
A legfontosabb adatok
- Ki végzi
- Shanxi Bethune Hospital
- Hol
- Kína1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 40 fő, tervezett
- Kezdés
- 2025. ápr. 15.
- Várható befejezés
- 2027. aug. 31.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
- A vizsgált kezelések
- Hybrid Closed-Loop Artificial Pancreas System
- A regiszteradat frissítve
- 2025. április 23.
Ki vehet részt
- Életkor
- 18 év – 75 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 15 feltétel megnézéseKevesebb
Ki vehet részt
- Aged between 18 and 75 years old
- Patients who have undergone neurosurgical procedures for intracranial hemorrhage (including subdural hemorrhage, basal ganglia hemorrhage, and subarachnoid hemorrhage), have a Glasgow Coma Scale score of 12 or higher after leaving the intensive care unit, receive enteral nutrition postoperatively, and have a previously established diagnosis of type 2 diabetes mellitus, or meet the diagnostic criteria for type 2 diabetes mellitus in the "Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes" (2020 edition)
- Fasting blood glucose ≥ 7.0 mmol/L or random blood glucose ≥ 11.1 mmol/L
- Those who have signed the informed consent form and are willing to participate in this clinical trial voluntarily
Ki nem vehet részt
- Patients who develop severe complications during or after surgery and are judged by the researcher as unfit for enrollment
- Patients with type 1 diabetes or other special types of diabetes
- Patients who are allergic to the drugs involved in the clinical diagnosis and treatment plan
- Patients with allergic constitution and those who are allergic to adhesive tape
- Patients with skin diseases such as rashes and prurigo, or those with abnormal coagulation function
- Patients with impaired consciousness or mental diseases, who lack self-control and cannot express themselves clearly
- Patients with severe cardiac and renal dysfunction: those with cardiac function above grade III; those with serum creatinine exceeding 442 μmol/L
- Patients with diseases that affect glucose metabolism, such as hyperthyroidism, hypothyroidism, Cushing's syndrome, etc
- Patients with diabetic emergencies, such as diabetic ketoacidosis, hyperglycemic hyperosmolar coma, etc
- Populations and contraindications that are not suitable for insulin pump treatment
- Other situations that the researcher deems inappropriate for participating in the clinical trial
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 75 év között vagy?
Ez a vizsgálat jelenleg itt érhető el: Kína.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
In this study, we plan to use an open-source hybrid closed-loop artificial pancreas system and a combination of a traditional insulin pump and continuous glucose monitoring (CGM) respectively to conduct short-term intensive insulin treatment for patients with type 2 diabetes mellitus (T2DM) during the perioperative period who are hospitalized in the Department of Neurosurgery of Shanxi Bethune Hospital. By comparing the blood glucose control status of patients under different intensive insulin treatment regimens and other clinical indicators such as postoperative complications, we will comprehensively evaluate the clinical efficacy and safety of the hybrid closed-loop artificial pancreas system.
A vizsgálat 2 csoportja
- Traditional insulin pump groupPlacebo, összehasonlításként
Based on the patient's weight, the total daily insulin requirement is calculated at 0.3\~0.6U/(kg\*d) and distributed before meals according to the specific conditions of the patient. Continuous glucose monitoring system is used along with daily capillary blood glucose monitoring (fasting, 2 hours after breakfast, lunch, and dinner, totaling 4 times). Insulin doses are adjusted according to the patient's blood glucose level until the target blood glucose level is achieved.
Kezelés: Hybrid Closed-Loop Artificial Pancreas System
- Hybrid Closed-Loop Artificial Pancreas System GroupA vizsgált kezelés
The open-source hybrid closed-loop artificial pancreas system, utilizing ultra-rapid-acting insulin, was employed for perioperative blood glucose management in neurosurgery. Insulin requirements were calculated based on patient weight. The system auto-adjusted basal rates according to blood glucose, while bolus treatments were manually inputted by nurses following physician instructions. Continuous and daily capillary blood glucose monitoring were conducted.
Kezelés: Hybrid Closed-Loop Artificial Pancreas System
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Application of the Hybrid Closed-Loop Artificial Pancreas System in Neurosurgical Perioperative Hyperglycemic Patients: An Open, Randomized Controlled Trial
- Kérdések a feltételekről
- Forrás: NCT06909071: ki vehet részt
- A regiszteradat frissítve
- 2025. április 23.